Thrombosis

Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial

European Heart Journal

1 Aug 2025

Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial

European Heart Journal

27 Jun 2025

Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis

European Heart Journal

20 May 2025

Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy A clinical consensus statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy and the European Association for Haemophilia and Allied Disorders (EAHAD)

European Heart Journal - Cardiovascular Pharmacotherapy

26 Mar 2025

Plaque erosion risk and JAK2 V617F variant

European Heart Journal

7 Mar 2025

Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis

European Heart Journal

3 Dec 2024

Evolution of left ventricular thrombus on serial cardiovascular magnetic resonance imaging

European Heart Journal - Cardiovascular Imaging

22 Oct 2024

Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials

European Heart Journal

2 Sep 2024

The humanized platelet glycoprotein VI Fab inhibitor EMA601 protects from arterial thrombosis and ischaemic stroke in mice

European Heart Journal

16 Aug 2024

Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score

European Heart Journal

17 Jul 2024

Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis

European Heart Journal - Cardiovascular Pharmacotherapy

16 May 2024

Low-dose colchicine for atherosclerosis: long-term safety

European Heart Journal

10 Apr 2024

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

European Heart Journal

28 Feb 2024

Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial

European Heart Journal - Cardiovascular Pharmacotherapy

29 Jan 2024

Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h

European Heart Journal

12 Nov 2023

Platelet biology and function: plaque erosion vs. rupture

European Heart Journal

6 Nov 2023

Factor XIa inhibitors: collecting the clinical evidence

European Heart Journal - Cardiovascular Pharmacotherapy

1 Nov 2023

Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study

European Heart Journal - Cardiovascular Pharmacotherapy

31 Aug 2023

Inflammation in acute myocardial infarction: the good, the bad and the ugly

European Heart Journal

17 Aug 2023

Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials

European Heart Journal - Cardiovascular Pharmacotherapy

14 Sep 2022

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

European Heart Journal

7 Apr 2021

Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves

European Heart Journal

3 Apr 2019

Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis

European Heart Journal

5 Nov 2018

Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study

European Heart Journal

30 Oct 2018

Recommended Reading on Thrombosis

ESC Working Group on Thrombosis

Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial

Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial

Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis

Plaque erosion risk and <em>JAK2</em> V617F variant

Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis

Evolution of left ventricular thrombus on serial cardiovascular magnetic resonance imaging

Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials

The humanized platelet glycoprotein VI Fab inhibitor EMA601 protects from arterial thrombosis and ischaemic stroke in mice

Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score

Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis

Low-dose colchicine for atherosclerosis: long-term safety

Semaglutide and cardiovascular outcomes by baseline HbA<sub>1c</sub> in diabetes: the SUSTAIN 6 and PIONEER 6 trials

Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial

Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h

Platelet biology and function: plaque erosion vs. rupture

Factor XIa inhibitors: collecting the clinical evidence

Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study

Inflammation in acute myocardial infarction: the good, the bad and the ugly

Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

<em>Staphylococcus aureus</em> endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves

Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis

Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study